» Articles » PMID: 32048029

Surgical Nodal Management in Hypopharyngeal and Laryngeal Cancer

Overview
Date 2020 Feb 13
PMID 32048029
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study is to compare pre-therapeutic staging of the loco-regional lymphatic basin and subsequent surgical management in cN0 versus cN+ hypopharyngeal and laryngeal cancer patients.

Methods: We analyzed all hypopharyngeal and laryngeal carcinoma patients treated surgically at a single quaternary medical care and cancer center between 2004 and 2014. We established two groups for patients who underwent neck dissection comparing patients with a low LNR (lymph node ratio) to one with a high LNR. Regarding the cN0 cohort, elective neck dissection was evaluated as a secondary predictor variable. Comorbidities, such as anemia and renal insufficiency, were analyzed as potentially influencing disease-free (DFS) and overall survival (OS).

Results: A total of 310 patients (185 glottic and 125 supraglottic/hypopharyngeal carcinoma) were included. Pre-therapeutic neck MRI-/CT-scan and concomitant neck ultrasound revealed cN+ status in 144 patients resulting in a significant over-staging in 63 patients (44%) who were rated as being pN0 after histological examination. 166 patients were staged cN0 and 21 underwent elective neck dissection (11 local advanced glottic and 10 supraglottic/hypopharyngeal carcinoma). Two cN0 patients showed occult cervical lymph node metastases (10%). Furthermore, we could detect a significant negative impact of the LNR divided by the number of dissected lymph nodes and OS.

Conclusion: The pre-therapeutic clinical evaluation of lymphatic outgrowth is over-staged. OS decreases with increasing LNR divided by the number of dissected lymph nodes. Renal insufficiency and anemia are significant negative factors, decreasing both OS and DFS.

Citing Articles

Dual-energy computed tomography for predicting cervical lymph node metastasis in laryngeal squamous cell carcinoma.

Tu J, Lin G, Chen W, Cheng F, Ying H, Kong C Heliyon. 2024; 10(16):e35528.

PMID: 39229502 PMC: 11369477. DOI: 10.1016/j.heliyon.2024.e35528.


Development and validation of a diagnostic model for predicting cervical lymph node metastasis in laryngeal and hypopharyngeal carcinoma.

Wu X, Xie Y, Zeng W, Wu X, Chen J, Li G Front Oncol. 2024; 14:1330276.

PMID: 38841164 PMC: 11151090. DOI: 10.3389/fonc.2024.1330276.


Generation of a Realistic Synthetic Laryngeal Cancer Cohort for AI Applications.

Katalinic M, Schenk M, Franke S, Katalinic A, Neumuth T, Dietz A Cancers (Basel). 2024; 16(3).

PMID: 38339389 PMC: 10854797. DOI: 10.3390/cancers16030639.


The role of adjuvant therapy in pT4N0 laryngectomized patients: Multicentric observational study.

Mattioli F, Serafini E, Lo Manto A, Mularoni F, Abeshi A, Lionello M Head Neck. 2022; 45(1):197-206.

PMID: 36250285 PMC: 10092371. DOI: 10.1002/hed.27225.


Long-term survival trend after primary total laryngectomy for patients with locally advanced laryngeal carcinoma.

Lin Z, Lin H, Chen Y, Xu Y, Chen X, Fan H J Cancer. 2021; 12(4):1220-1230.

PMID: 33442420 PMC: 7797640. DOI: 10.7150/jca.50404.


References
1.
Backes C, Bier H, Knopf A . Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma. Oncotarget. 2017; 8(48):84320-84328. PMC: 5663598. DOI: 10.18632/oncotarget.21035. View

2.
Erdag T, Karas C, Ikiz A, Guneri E, Ceryan K, Sarioglu S . [The incidence of level I metastasis in laryngopharyngeal squamous cell carcinoma]. Kulak Burun Bogaz Ihtis Derg. 2004; 11(6):166-9. View

3.
Pillsbury 3rd H, Clark M . A rationale for therapy of the N0 neck. Laryngoscope. 1997; 107(10):1294-315. DOI: 10.1097/00005537-199710000-00004. View

4.
Gallo O, Deganello A, Scala J, De Campora E . Evolution of elective neck dissection in N0 laryngeal cancer. Acta Otorhinolaryngol Ital. 2007; 26(6):335-44. PMC: 2639990. View

5.
Becker C, Dahlem K, Lange K, Ketterer M, Pfeiffer J . Predictive value of comorbidity and anemia on outcome in patients with sinonasal carcinoma. J Craniomaxillofac Surg. 2018; 46(8):1373-1378. DOI: 10.1016/j.jcms.2018.05.009. View